COLL

Collegium Pharmaceutical (COLL)

About Collegium Pharmaceutical (COLL)

Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Details

Daily high
$29.81
Daily low
$28.01
Price at open
$29.01
52 Week High
$50.79
52 Week Low
$28.01
Market cap
955.8M
Dividend yield
0.00%
Volume
978,512
Avg. volume
469,552
P/E ratio
23.88

Collegium Pharmaceutical News

Details

Daily high
$29.81
Daily low
$28.01
Price at open
$29.01
52 Week High
$50.79
52 Week Low
$28.01
Market cap
955.8M
Dividend yield
0.00%
Volume
978,512
Avg. volume
469,552
P/E ratio
23.88